18th October 2020 Product update: rapidmicrobiology staff writer
New CE-Marked COVID-19 Antibody Test Delivers Results in One Minute
A 1-minute-to-result COVID-19 serology test has obtained CE-marking.
The INSTI® COVID-19 Antibody Test, from bioLytical Laboratories, is designed to detect IgA, IgM and IgG antibodies to SARS-CoV-2 in a patient’s whole blood, serum or plasma sample.
It is the only test of its kind to use innovative flow-through technology to deliver results, making it far faster than other antibody tests currently available.
In 2016 bioLytical released the fastest HIV test on the market, the 60-second INSTI® HIV test, which showed very high sensitivity and specificity in a study published in the Journal of Clinical Virology.
With current tests offering lower performance, more complex procedures as well as longer wait times, the INSTI® COVID-19 Antibody Test provides a cost-effective solution for COVID-19 antibody testing.
The INSTI® COVID-19 Antibody Test is completely portable, does not require additional equipment and can be performed in a multitude of settings with easy-to-interpret results. Test providers actually have the advantage of running more tests in less time, due to INSTI®'s market-leading speed.
The company received $633,000 in federal funding from the National Research Council of Canada Industrial Research Assistance Program (NRC IRAP) to develop, optimize, and produce a one-minute COVID-19 antibody test.
bioLytical is also filing for Emergency Use Authorization (EUA) from the US FDA.
Date Published: 18th October 2020
Source article link: View
Note: This content has been edited by a rapidmicrobiology staff writer for style and content.
Beckman Coulter Launches First High
Creative Diagnostics Launches SARS-CoV-2 Immunoassay